AR022475A1 - Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria. - Google Patents
Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria.Info
- Publication number
- AR022475A1 AR022475A1 ARP000100437A ARP000100437A AR022475A1 AR 022475 A1 AR022475 A1 AR 022475A1 AR P000100437 A ARP000100437 A AR P000100437A AR P000100437 A ARP000100437 A AR P000100437A AR 022475 A1 AR022475 A1 AR 022475A1
- Authority
- AR
- Argentina
- Prior art keywords
- prevention
- reduction
- events associated
- cardiovascular events
- coronary intervention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Un método para la prevencion o la reduccion de episodios cardiovasculares asociados con intervenciones coronarias en mamíferos, particularmente en personasque comprende administrar al sujeto ácido N-(3, 4-dimetoxicinamoil)antranílico(N-5)o una sal del mismo aceptable farmacéuticamente en una dosis diaria deaproximadamente 300mg a aproximadamente 1.100mg en asociacion con la intervencion coronaria.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11846399P | 1999-02-03 | 1999-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022475A1 true AR022475A1 (es) | 2002-09-04 |
Family
ID=22378760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000100437A AR022475A1 (es) | 1999-02-03 | 2000-02-02 | Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1180027A4 (es) |
| JP (1) | JP2002536326A (es) |
| KR (1) | KR20010101933A (es) |
| CN (1) | CN1338930A (es) |
| AR (1) | AR022475A1 (es) |
| AU (1) | AU2978500A (es) |
| BR (1) | BR0007901A (es) |
| CA (1) | CA2361578A1 (es) |
| CO (1) | CO5160246A1 (es) |
| HU (1) | HUP0200148A3 (es) |
| IL (1) | IL144719A0 (es) |
| MX (1) | MXPA01007833A (es) |
| NO (1) | NO20013789L (es) |
| PL (1) | PL349926A1 (es) |
| TR (1) | TR200102262T2 (es) |
| WO (1) | WO2000045810A1 (es) |
| ZA (1) | ZA200106297B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097650B2 (en) * | 2005-07-27 | 2012-01-17 | The Trustees Of Columbia University In The City Of New York | Method of treating a condition associated with phosphorylation of TASK-1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617407B2 (ja) * | 1992-09-14 | 1997-06-04 | キッセイ薬品工業株式会社 | 血管内膜細胞過剰増殖疾患の予防および治療剤 |
| WO1997009301A1 (fr) * | 1995-09-07 | 1997-03-13 | Kissei Pharmaceutical Co., Ltd. | Derives de 2-acylaminobenzamide, preventif et remede contre des maladies causees par une surmultiplication des cellules vasculaires de l'intima |
| US6019104A (en) * | 1996-12-30 | 2000-02-01 | Kissei Pharmaceutical Co., Ltd. | Method for the treatment or prevention of restenosis associated with coronary intervention |
-
2000
- 2000-02-02 IL IL14471900A patent/IL144719A0/xx unknown
- 2000-02-02 CN CN00803386A patent/CN1338930A/zh active Pending
- 2000-02-02 KR KR1020017009743A patent/KR20010101933A/ko not_active Application Discontinuation
- 2000-02-02 HU HU0200148A patent/HUP0200148A3/hu unknown
- 2000-02-02 WO PCT/US2000/002611 patent/WO2000045810A1/en not_active Application Discontinuation
- 2000-02-02 AU AU29785/00A patent/AU2978500A/en not_active Abandoned
- 2000-02-02 CA CA002361578A patent/CA2361578A1/en not_active Abandoned
- 2000-02-02 AR ARP000100437A patent/AR022475A1/es unknown
- 2000-02-02 MX MXPA01007833A patent/MXPA01007833A/es unknown
- 2000-02-02 TR TR2001/02262T patent/TR200102262T2/xx unknown
- 2000-02-02 BR BR0007901-4A patent/BR0007901A/pt not_active Application Discontinuation
- 2000-02-02 EP EP00908440A patent/EP1180027A4/en not_active Withdrawn
- 2000-02-02 PL PL00349926A patent/PL349926A1/xx not_active Application Discontinuation
- 2000-02-02 JP JP2000596930A patent/JP2002536326A/ja not_active Withdrawn
- 2000-02-03 CO CO00006605A patent/CO5160246A1/es unknown
-
2001
- 2001-07-31 ZA ZA200106297A patent/ZA200106297B/en unknown
- 2001-08-02 NO NO20013789A patent/NO20013789L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1180027A4 (en) | 2004-11-17 |
| AU2978500A (en) | 2000-08-25 |
| CO5160246A1 (es) | 2002-05-30 |
| HUP0200148A3 (en) | 2003-06-30 |
| PL349926A1 (en) | 2002-10-21 |
| NO20013789D0 (no) | 2001-08-02 |
| JP2002536326A (ja) | 2002-10-29 |
| WO2000045810A1 (en) | 2000-08-10 |
| MXPA01007833A (es) | 2002-06-21 |
| IL144719A0 (en) | 2002-06-30 |
| HUP0200148A2 (hu) | 2002-05-29 |
| ZA200106297B (en) | 2002-07-31 |
| KR20010101933A (ko) | 2001-11-15 |
| CN1338930A (zh) | 2002-03-06 |
| EP1180027A1 (en) | 2002-02-20 |
| NO20013789L (no) | 2001-09-28 |
| BR0007901A (pt) | 2001-10-30 |
| TR200102262T2 (tr) | 2002-02-21 |
| CA2361578A1 (en) | 2000-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69520768D1 (de) | Pharmazeutische Zubereitungen, die Fluoxetin enthalten | |
| DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
| EA200200106A1 (ru) | Фармацевтическая композиция леводопа/карбидопа/энтакапон | |
| NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| AP2001002291A0 (en) | Novel method of treatment. | |
| WO2001017517A3 (en) | Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer | |
| EE04606B1 (et) | H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks | |
| RS54050B1 (en) | FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS | |
| BR0013935A (pt) | IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos | |
| BR0213293A (pt) | Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia | |
| PT1425005E (pt) | Composicao farmaceutica que compreende lumiracoxib | |
| CO5190674A1 (es) | Tratamiento de desordenes neuroticos desordenes neuroticos | |
| ATE311928T1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
| DE60026491D1 (de) | Melagatran zur behandlung von entzündungen | |
| EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
| ATE8739T1 (de) | Pharmazeutische zubereitungen. | |
| AR022475A1 (es) | Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria. | |
| AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
| BR0012121A (pt) | Derivado de aminotetralina para terapia de doenças cardiovasculares | |
| NO960347L (no) | Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF | |
| CO5150206A1 (es) | Metodo para la prevencion o reduccion de episodios cardiovasculares asociados con intervenciones coronarias | |
| RU2001124669A (ru) | Способ профилактики паратифа телят | |
| ECSP003771A (es) | Metodo para prevenir la diarrea | |
| PA8505301A1 (es) | Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina | |
| MX9605153A (es) | Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas. |